1.
|
11 p, 1.2 MB |
Design of the β3-Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure Trial
/
Garcia-Lunar, Ines (Hospital Universitario Quirónsalud Madrid, UEM, Madrid, Spain) ;
Blanco, Isabel (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain) ;
Fernández-Friera, Leticia (HM Hospitales-Centro Integral de Enfermedades Cardiovasculares HM-CIEC, Madrid, Spain) ;
Prat-Gonzàlez, Susanna (Institut Clinic Cardiovascular, IDIBAPS, Hospital Clínic, University of Barcelona, Barcelona, Spain) ;
Jordà, Paloma (Institut Clinic Cardiovascular, IDIBAPS, Hospital Clínic, University of Barcelona, Barcelona, Spain) ;
Sánchez, Javier (Philips Healthcare Iberia, Madrid, Spain) ;
Pereda, Daniel (Institut Clinic Cardiovascular, IDIBAPS, Hospital Clínic, University of Barcelona, Barcelona, Spain) ;
Pujadas, Sandra (Institut d'Investigació Biomèdica Sant Pau) ;
Rivas, Mercedes (Institut d'Investigació Biomèdica Sant Pau) ;
Solé-Gonzalez, Eduard (Parc de Salut Mar (Barcelona, Catalunya)) ;
Vázquez, Jorge (Cardiology Department, University Hospital Puerta de Hierro, University Autonoma de Madrid, Madrid, Spain) ;
Blázquez, Zorba (Cardiology Department, University Hospital 12 de Octubre, Universidad Complutense, Madrid, Spain) ;
García-Picart, Juan (Institut d'Investigació Biomèdica Sant Pau) ;
Caravaca, Pedro (Cardiology Department, University Hospital 12 de Octubre, Universidad Complutense, Madrid, Spain) ;
Escalera, Noemí (Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain) ;
Garcia-Pavia, Pablo (University Francisco de Vitoria (UFV), Pozuelo de Alarcon, Spain) ;
Delgado, Juan (Cardiology Department, University Hospital 12 de Octubre, Universidad Complutense, Madrid, Spain) ;
Segovia-Cubero, Javier (Cardiology Department, University Hospital Puerta de Hierro, University Autonoma de Madrid, Madrid, Spain) ;
Fuster, Valentín (Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York) ;
Roig, Eulalia (Institut d'Investigació Biomèdica Sant Pau) ;
Barberá, Joan Albert (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain) ;
Ibanez, Borja (IIS-Fundación Jiménez Díaz University Hospital, Madrid, Spain) ;
García-Álvarez, Ana (Institut Clinic Cardiovascular, IDIBAPS, Hospital Clínic, University of Barcelona, Barcelona, Spain) ;
Universitat Autònoma de Barcelona
Combined pre-and post-capillary hypertension (CpcPH) is a relatively common complication of heart failure (HF) associated with a poor prognosis. Currently, there is no specific therapy approved for this entity. [...]
2020 - 10.1016/j.jacbts.2020.01.009
JACC: Basic to Translational Science, Vol. 5 (march 2020) , p. 317-327
|
|